当前位置:首页 - 行情中心 - 傲农生物(603363) - 财务分析 - 现金流量表

傲农生物

(603363)

  

流通市值:72.22亿  总市值:87.72亿
流通股本:21.43亿   总股本:26.03亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,013,020,363.788,211,695,932.755,900,299,153.053,686,688,440.67
  收到其他与经营活动有关的现金130,701,853.32576,695,579.41283,053,682.97136,441,057.52
  经营活动现金流入小计2,143,722,217.18,788,391,512.166,183,352,836.023,823,129,498.19
  购买商品、接受劳务支付的现金1,929,360,176.417,145,739,982.745,323,159,008.483,371,284,492.34
  支付给职工以及为职工支付的现金189,022,954.1677,105,229.94494,654,057.87330,378,349.39
  支付的各项税费22,838,403.8978,815,324.5762,069,045.4446,484,728.61
  支付其他与经营活动有关的现金119,987,502.94733,787,562.15594,939,318.38391,069,272.37
  经营活动现金流出小计2,261,209,037.348,635,448,099.46,474,821,430.174,139,216,842.71
  经营活动产生的现金流量净额-117,486,820.24152,943,412.76-291,468,594.15-316,087,344.52
二、投资活动产生的现金流量:
  收回投资收到的现金548,583.066,171,387.072,250,0002,250,000
  取得投资收益收到的现金3,611,529.233,041,275.591,087,228.9576,771.93
  处置固定资产、无形资产和其他长期资产收回的现金净额965,0964,692,305.32,561,701.7344,121.7
  处置子公司及其他营业单位收到的现金净额-64,593,156.1256,132,093.2256,132,093.22
  收到的其他与投资活动有关的现金4,541,975.1614,494,260.272,721,358.562,321,355.13
  投资活动现金流入小计9,667,183.4592,992,384.3564,752,382.4361,124,341.98
  购建固定资产、无形资产和其他长期资产支付的现金41,291,961.95229,897,677.94182,595,112.43132,008,436.77
  投资支付的现金200,00010,222,893.256,072,893.252,272,893.25
  取得子公司及其他营业单位支付的现金-389,574.83389,574.83-
  支付其他与投资活动有关的现金12,173,841.0323,530,816.289,302,461.886,966,280.08
  投资活动现金流出小计53,665,802.98264,040,962.3198,360,042.39141,247,610.1
  投资活动产生的现金流量净额-43,998,619.53-171,048,577.95-133,607,659.96-80,123,268.12
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,860,20031,958,095.918,044,32011,524,320
  其中:子公司吸收少数股东投资收到的现金3,860,20031,958,095.918,044,32011,524,320
  取得借款收到的现金109,000,000297,125,642.83235,327,329.21193,840,329.21
  收到其他与筹资活动有关的现金1,700,00064,613,109.5348,823,162.474,146,000
  筹资活动现金流入小计114,560,200393,696,848.26302,194,811.68209,510,649.21
  偿还债务支付的现金87,711,835.35519,825,408.66318,091,161.36260,528,174.16
  分配股利、利润或偿付利息支付的现金13,462,416.2106,971,694.4753,765,626.5340,190,388.01
  其中:子公司支付给少数股东的股利、利润7,850,00022,465,925.6918,015,925.6913,795,147.99
  支付其他与筹资活动有关的现金71,771,661.94333,648,316.63283,864,300.17195,205,147.2
  筹资活动现金流出小计172,945,913.49960,445,419.76655,721,088.06495,923,709.37
  筹资活动产生的现金流量净额-58,385,713.49-566,748,571.5-353,526,276.38-286,413,060.16
四、汇率变动对现金及现金等价物的影响-26,317.47-37,603.9-19,425.38-6,984.71
五、现金及现金等价物净增加额-219,897,470.73-584,891,340.59-778,621,955.87-682,630,657.51
  加:期初现金及现金等价物余额546,796,192.811,131,687,533.41,131,687,533.41,131,687,533.4
  期末现金及现金等价物余额326,898,722.08546,796,192.81353,065,577.53449,056,875.89
补充资料:
  净利润-89,408,894.36-375,393,633.1
  资产减值准备-60,942,041.88--
  固定资产和投资性房地产折旧-396,957,149.95-199,699,465.03
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-396,957,149.95-199,699,465.03
  无形资产摊销-11,933,252.59-5,979,679.16
  长期待摊费用摊销-27,171,107.63-13,310,706.8
  处置固定资产、无形资产和其他长期资产的损失--359,130.85--270,002.62
  固定资产报废损失-3,581,324.26-206,211.33
  公允价值变动损失-161,130--37,140
  财务费用-146,889,568.05-67,585,902.75
  投资损失-28,421,393.24--372,837,359.85
  递延所得税--4,854,895.89--22,683,702.71
  其中:递延所得税资产减少--3,303,142.52--21,918,437.48
    递延所得税负债增加--1,551,753.37--765,265.23
  存货的减少--320,175,344.16--207,036,503.11
  经营性应收项目的减少--435,759,451.43--306,687,312.4
  经营性应付项目的增加--94,149,518.06--114,497,819.06
  其他--376,782.42--4,313,564.21
  债务转为资本-1,005,937,029.69-685,736,227.98
  不涉及现金收支的投资和筹资活动金额其他项目-79,456,694.41--
  现金的期末余额-546,796,192.81-449,056,875.89
  减:现金的期初余额-1,131,687,533.4-1,131,687,533.4
  现金及现金等价物的净增加额--584,891,340.59--682,630,657.51
公告日期2026-04-282026-04-232025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑